Biotechnology initial public offerings are showing sustained signs of life for the first time in two years, and Kyverna Therapeutics' larger-than-expected raise on Wednesday is the latest example. The ...
CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Peter Maag, Ph.D., is the Chief Executive Officer and President of CareDx, Inc. (NASD:CDNA). Dr. Maag has over 20 years of executive management experience in the pharmaceutical and diagnostic industry ...
BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company that discovers, develops and commercializes high value, non-invasive tests to monitor immune status in transplant ...
Good day, ladies and gentlemen, and welcome to the CareDx Third Quarter 2017 Earnings Call. Today’s conference is being recorded. And at this time, I’d like to turn the floor over to David Clair, ICR, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Peter Maag, the Emeryville-based president and global head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results